Sultopride
NERVOUS SYSTEM
Also known as: (+/-)-Sultopride, barnetil, sultopride HCl, sultopride hydrochloride
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Sultopride is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including DRD2 and DRD3.
- Molecular targets: DRD2 and DRD3 (2 listed in DrugCentral).
- ATC code: N05AL02 (Benzamides).
- Molecular formula: C17H26N2O4S; molecular weight 354.47 g/mol.
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| D(2) dopamine receptor | DRD2 | unknown | Ki 8.57 |
| D(3) dopamine receptor | DRD3 | unknown | Ki 8.42 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N05AL02 | NERVOUS SYSTEM › PSYCHOLEPTICS › ANTIPSYCHOTICS › Benzamides |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Sultopride is on its molecule page.
| Molecular formula | C17H26N2O4S |
|---|---|
| Molecular weight | 354.47 g/mol |
| CAS number | 53583-79-2 |
| InChIKey | UNRHXEPDKXPRTM-UHFFFAOYSA-N |
| PubChem CID | 5357 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Sultopride work?
Its molecular targets in DrugCentral include DRD2 and DRD3.
What is the chemical formula of Sultopride?
Sultopride has the molecular formula C17H26N2O4S and a molecular weight of 354.47 g/mol.
Browse: all drugs starting with S · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2541 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL277945 — compound record and bioactivity
- PubChem CID 5357 — chemical identifiers
- DrugBank DB13273 — drug record
- FDA UNII AA0G3TW31W — substance identity
- UniProt P14416 (DRD2) — target protein
- UniProt P35462 (DRD3) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.